Skip to content

Japt.gr

Hellenic Atherosclerosis Society
  • HOME
  • ABOUT
    • SCOPE
    • EDITORIAL BOARD
  • CURRENT ISSUE
  • ARCHIVES
    • VOLUME 13 (2022)
      • Volume 13 – Issue 3
      • Volume 13 – Issue 2
      • Volume 13 – Issue 1
      • Volume 13 – Suppl. 1
    • VOLUME 12 (2021)
      • Volume 12 – Issue 1
      • Volume 12 – Issue 2
      • Volume 12 – Issue 3
      • Volume 12 – Suppl. 1
    • VOLUME 11 (2020)
      • Volume 11 – Issue 1
      • Volume 11 – Issue 2
      • Volume 11 – Issue 3
      • Volume 11 – Suppl. 1
    • VOLUME 10 (2019)
      • Volume 10 – Issue 1
      • Volume 10 – Suppl. 1
    • VOLUME 9 (2018)
      • Volume 9 – Issue 1
      • Volume 9 – Issue 2
      • Volume 9 – Issue 3
      • Volume 9 – Issue 4
    • VOLUME 8 (2017)
      • Volume 8 – Issue 1
      • Volume 8 – Issue 2
      • Volume 8 – Issue 3
      • Volume 8 – Issue 4
    • VOLUME 7 (2016)
      • Volume 7 – Issue 1
      • Volume 7 – Issue 2
      • Volume 7 – Issue 3
      • Volume 7 – Issue 4
    • VOLUME 6 (2015)
      • Volume 6 – Issue 1
      • Volume 6 – Issue 2
      • Volume 6 – Issue 3
      • Volume 6 – Issue 4
    • VOLUME 5 (2014)
      • Volume 5 – Issue 1
      • Volume 5 – Issue 2
      • Volume 5 – Issue 3
    • VOLUME 4 (2013)
      • Volume 4 – Issue 1
      • Volume 4 – Issue 2
      • Volume 4 – Issue 3
    • VOLUME 3 (2012)
      • Volume 3 – Issue 3
  • FOR AUTHORS
  • SUBMIT MANUSCRIPT
  • CONTACT
  • Menu

Tag Archives: Familial hypercholesterolemia

PCSK9 inhibitors: The breakthrough lipid-lowering treatment at real-life setting – A 2-year regional lipid clinic experience

Georgia Anastasiou, George Liamis, Haralampos Milionis, Moses Elisaf, Eliza Christopoulou, Theodora Dimitriou, Evangelos N. Liberopoulos

Familial hypercholesterolemia is undertreated in clinical practice

E. Liberopoulos, F. Barkas, G. Liamis, M. Elisaf

Updated Guidelines of the Hellenic Society of Atherosclerosis for the diagnosis and treatment of dyslipidemia-2014

Moses Elisaf, Christos Pitsavos, Evangelos Liberopoulos, Kostas Tziomalos, Vasilios Athyros

The impact of the Low Density Lipoprotein Receptor gene mutation type on carotid intima media thickness in families with familial hypercholesterolemia.

Vasiliki Metaxa, Ioannis Skoumas, Christos Pitsavos, Evaggelos Oikonomou, Constantina Masoura, Christodoulos Stefanadis

CURRENT ISSUE

Empagliflozin in mice fed on a fast-food diet: Preliminary biochemical data
The role of epidemiology research in economic evaluation for Health Technology Assessment
Type 1 diabetes mellitus and cardiovascular risk: A short review
Health literacy in relation to health outcomes in hypertension: A systematic review
A Collection of Position Statements and Opinions on e-cigarette use and cardiovascular disease: On behalf of the Working Group on Epidemiology of the Hellenic Atherosclerosis Society

Keywords

acute coronary syndrome (4) Arterial hypertension (3) arterial stiffness (5) Atherosclerosis (19) blood pressure (3) cardiovascular disease (22) cardiovascular diseases (6) cardiovascular events (3) Cardiovascular risk (5) coronary artery disease (4) coronary heart disease (4) COVID-19 (4) diabetes (3) diabetes mellitus (9) diet (4) dyslipidemia (14) ezetimibe (4) Familial hypercholesterolemia (4) Heart failure (5) hypertension (7) inflammation (9) Ischemic stroke (3) lipoproteins (4) longevity (3) Mediterranean diet (7) metabolic syndrome (7) mortality (7) NAFLD (3) non-alcoholic fatty-liver disease (4) obesity (7) omega-3 fatty acids (3) outcome (3) PCSK9 inhibitors (4) physical activity (4) platelets (8) primary prevention (3) pulse wave velocity (3) rosuvastatin (3) smoking (3) statins (14) stroke (3) thrombosis (4) treatment (5) type 2 diabetes (3) type 2 diabetes mellitus (4)
Journal of Atherosclerosis Prevention and Treatment    ©2023
A SiteOrigin Theme